Michael Fisher

Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

L. Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux et al. · The Lancet Diabetes & Endocrinology · 2020 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3

Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre

L. Ranganath, Milad Khedr, Anna M. Milan et al. · Molecular Genetics and Metabolism · 2018 · 104 citations · Full text

Medicine, Internal Medicine, Molecular Pathology +1

Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial

Andrew Morrow, Thomas J. Ford, Kenneth Mangion et al. · American Heart Journal · 2020 · 68 citations · Full text

Medicine, Cardiology, Pharmacology +13

Gated MR imaging of the heart: intracardiac signals in patients and healthy subjects.

Gustav K. von Schulthess, Michael Fisher, L E Crooks et al. · Radiology · 1985 · 66 citations

Medicine, Cardiology, Radiology +16

Cardiovascular manifestations of Alkaptonuria

Stephen Pettit, Michael Fisher, James A. Gallagher et al. · Journal of Inherited Metabolic Disease · 2011 · 55 citations

Medicine, Cardiology, Internal Medicine +4